Reports and Briefs on Healthcare in China

Published within

« | 1 | 2 | » »|

Type Product title / description Pub Price
Report
Report

Biosimilars: China Update

Biosimilars: China Update provides analysis on the Chinese biogenerics market. It includes an overview of drivers and resistors to biogeneric uptake, market access strategies, key biogeneric players and future development trends.

Published By Datamonitor
22 Sep 2011 $1520
Buy
Report
Report

China Pharmaceutical Market Overview - Growth set to continue fueled by economic strength and healthcare reforms

Overview of the Chinese pharmaceutical market including socioeconomic and demographic trends, regulatory issues, generics and biosimilars analysis and pharmaceutical company infrastructure analysis.

Published By Datamonitor
25 Nov 2010 $7600
Buy
Report
Report

Orphan Drug Trends

Datamonitor’s report Orphan Drug Trends provides an overview of orphan drug regulations in the major pharmaceutical markets, including pricing and reimbursement issues and an analysis of Big Pharma’s growing interest in orphan drugs.

Published By Datamonitor
25 Nov 2011 $2800
Buy
Report
Report

Pharmaceutical Key Trends 2011 Overview - Key strategic trends in the pharmaceutical industry

Global analysis of socio-demographic and economic trends, rising healthcare costs, intensifying cost-containment and regulatory pressures, the patent cliff as well insight into the pharmaceutical industry’s strategic responses to drive profitability.

Published By Datamonitor
20 May 2011 $1520
Buy
Report
Report

Pharmaceutical Key Trends 2011: Biosimilar Market Overview

Comparative analysis of biosimilar drivers and resistors, key players, market access, pricing, and future launches across multiple markets including: the US, Japan, France, Germany, Italy, Spain, the UK, Australia, Brazil, Russia, India and China.

Published By Datamonitor
23 Feb 2011 $2800
Buy
Report
Report

Pharmaceutical Key Trends 2011: Generics Market Overview

Analysis on the global generics market. It includes an overview of drivers and resistors to generic uptake, key generics players, and opportunities for the generics industry.

Published By Datamonitor
18 Apr 2011 $2800
Buy
Report
Report

Pharmaceutical Key Trends 2011: Healthcare System and Drug Regulatory Overview

Analysis of healthcare expenditure, reforms, pricing and reimbursement and drug regulation across multiple markets including: the US, Japan, France, Germany, Italy, Spain, the UK, Australia, Brazil, Russia, India and China.

Published By Datamonitor
25 Mar 2011 $2800
Buy
Report
Report

Pharmaceutical Key Trends 2011: Pharmaceutical Industry Infrastructure Overview

Overview of cost-cutting, M&A and R&D trends across multiple markets including: the US, Japan, France, Germany, Italy, Spain, the UK, Australia, Brazil, Russia, India and China.

Published By Datamonitor
31 Mar 2011 $2800
Buy
Report
Report

Pharmaceutical Key Trends 2011: Prescription Pharmaceutical Sales Overview

An analysis of global sales forecasts for the top 50 companies during 2010–15.

Published By Datamonitor
28 Feb 2011 $1520
Buy
Report
Report

Pharmaceutical Key Trends 2011: Socio-Demographic and Economic Overview

Analysis of socio-demographic and economic trends across multiple markets including: the US, Japan, France, Germany, Italy, Spain, the UK, Australia, Brazil, Russia, India and China.

Published By Datamonitor
13 Apr 2011 $1520
Buy

« | 1 | 2 | » »|

No help is available.